Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Kuraray Co. Ltd.

Latest From Kuraray Co. Ltd.

U.K.’s Midatech Develops Transbuccal Insulin Using Gold Nanoparticles

The biocompatible gold nanoparticle technology being developed by the U.K. biotech can be used to carry insulin quickly to its site of action, and is also being evaluated with GLP-1 agonists and oncologics.

BioPharmaceutical United Kingdom
See All

Company Information

  • Industry
  • Miscellaneous
  • Therapeutic Areas
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • Asia
      • Pacific Rim
        • Japan
  • Parent & Subsidiaries
  • Kuraray Co. Ltd.
  • Senior Management
  • Hisao Nakakmura, Pres. & CEO
  • Contact Info
  • Kuraray Co. Ltd.
    Phone: (81) 6 34821111
    12-39 Umeda, 1 - Chome Kita Ku
    Osaka, 530
    Japan
Advertisement
Advertisement
UsernamePublicRestriction

Register